Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging double-blind placebo-controlled trial of vaginal oxytocin gel in postmenopausal women with vaginal atrophy
2011-005465-20Phase 2Completed
- Sponsor
- PeP-Tronic Medical
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in vaginal atrophy comparing Vagitocin dose arm(s) with Placebo (2 arms). Primary endpoint: Change in percentage of superficial cells at 7 weeks. Started Dec 2011; status: completed.
02
Drugs
vagitocin
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on 2011-005465-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005465-20.